| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/09/1998 | WO1998014480A1 G protein-coupled receptor antagonists |
| 04/09/1998 | WO1998014471A1 Calcium-integrin binding protein |
| 04/09/1998 | WO1998014467A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | WO1998014466A1 Polymorphisms and new genes in the region of the human hemochromatosis gene |
| 04/09/1998 | WO1998014464A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 04/09/1998 | WO1998014463A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF |
| 04/09/1998 | WO1998014461A1 NOVEL spsB |
| 04/09/1998 | WO1998014210A1 Method for treating allergic lung disease |
| 04/09/1998 | WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | WO1998002547A3 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 04/09/1998 | WO1998001557A3 Mammalian chemokine reagents |
| 04/09/1998 | WO1998001549A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 04/09/1998 | WO1997048804A3 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 04/09/1998 | DE19640733A1 Polypeptide than binds to CD30 without cell activation |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2647169A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2268013A1 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | CA2267675A1 Method for treating allergic lung disease |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267641A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | CA2267421A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | CA2267202A1 Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/09/1998 | CA2267097A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2267092A1 Mammalian chemokines |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2266327A1 Novel receptor that causes cell death |
| 04/09/1998 | CA2265466A1 Human sulfonylurea receptor surh |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/09/1998 | CA2236914A1 Interleukin-1.beta. converting enzyme like cysteine protease |
| 04/08/1998 | EP0834740A1 Anti-glu17-osteocalcin antibody |
| 04/08/1998 | EP0834568A2 Novel saliva binding protein |
| 04/08/1998 | EP0834564A2 A mouse genomic clone of the CC-CKR5 receptor |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834561A1 A gene related to migraine in man |
| 04/08/1998 | EP0834557A1 Monoclonal antibodies to detergents and their degradation products, and their use in immunoassays |
| 04/08/1998 | EP0834145A1 A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
| 04/08/1998 | EP0833929A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 04/08/1998 | EP0833921A1 ADHERENCE GENE FROM $i(HELICOBACTER PYLORI) AND POLYPEPTIDE CODED THEREBY |
| 04/08/1998 | EP0833918A1 Nucleic acid molecule and its uses in determining pathogenicity of staphylococcus |
| 04/08/1998 | EP0833917A2 Malarial pre-erythrocytic stage polypeptide molecules |
| 04/08/1998 | EP0833916A1 Decorin binding protein compositions and methods of use |
| 04/08/1998 | EP0833915A1 Plant regulatory proteins iii |
| 04/08/1998 | EP0833911A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 04/08/1998 | EP0833910A1 Cytoplasmic modulators of integrin regulation/signaling |
| 04/08/1998 | EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
| 04/08/1998 | EP0833906A2 Novel ctla4/cd28 ligands and uses therefor |
| 04/08/1998 | EP0833905A1 p-53 BINDING PROTEIN CALLED Mdmx AND ENCODING SEQUENCES FOR SAID PROTEIN |
| 04/08/1998 | EP0833846A1 Human g-protein coupled receptor (hetgq23) |
| 04/08/1998 | EP0833843A2 Depigmenting activity of agouti signal protein and peptides thereof |
| 04/08/1998 | EP0833840A1 Hypoxia inducible factor-1 and method of use |
| 04/08/1998 | EP0833838A1 Methods for reducing background binding in antibody preparations |
| 04/08/1998 | EP0833834A1 Dna sequence and encoded mammary-specific breast cancer protein |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833663A1 Carbohydrate-mediated coupling of peptides to immunoglobulins |
| 04/08/1998 | EP0833653A1 Serum immunoregulatory polypeptides and uses therefor |
| 04/08/1998 | EP0833650A1 P-selectin ligands and related molecules and methods |
| 04/08/1998 | EP0833648A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0638067B1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 04/08/1998 | EP0630405B1 Novel V28 seven transmembrane receptor |
| 04/08/1998 | EP0439508B1 Polyethylene glycolcol (peg)-protein adducts and process for their fractionation |
| 04/08/1998 | CN1178537A Anti-TPO monoclonal antibody |
| 04/07/1998 | US5736625 Method for stabilizing proteins with saccharide linked protein polymer conjugates |
| 04/07/1998 | US5736511 Methods for treatment using acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 04/07/1998 | US5736509 Cyclic peptide surface feature mimics of endothelin |
| 04/07/1998 | US5736396 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/07/1998 | US5736389 Treatment of colorectal cancer |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5736362 An isolated nucleic acid comprising nucleotide sequence encoding amino acid sequence 25-276 of a rye grass pollen protein |
| 04/07/1998 | US5736357 Cathespin O protease |
| 04/07/1998 | US5736344 Determining bone collagen decomposition by reacting blood sample with antibody(which is specific for pyridinolines) to form an immunocomplex which can be measured to indicate levels of collagen breakdown |
| 04/07/1998 | US5736341 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736338 Method of diagnosing Neoplastic disease by detecting increased expression of human MDM2 protein |
| 04/07/1998 | US5736328 Hybridization assays for detecting the presence of an AIDS-associated virus |
| 04/07/1998 | US5736325 Detecting presence or absence of mutation leading to pseudodeficiency phenotype in each allele of arylsulfatase a gene |
| 04/07/1998 | US5736321 Peptides effective for diagnosis and detection of hepatitis C infection |
| 04/07/1998 | US5736317 Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium |
| 04/07/1998 | US5736139 Treatment of Clostridium difficile induced disease |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736136 Immunoglobulin infusion in xenotransplantation |
| 04/07/1998 | CA1339801C Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 04/07/1998 | CA1339798C Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans |
| 04/02/1998 | WO1998013498A1 Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013492A2 Isolation and use of motoneuronotrophic factors |
| 04/02/1998 | WO1998013490A2 A gene related to migraine in man |
| 04/02/1998 | WO1998013489A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | WO1998013484A1 Two human cathepsin proteins |
| 04/02/1998 | WO1998013478A2 Antifungal proteins, dna coding therefore, and hosts incorporating same |
| 04/02/1998 | WO1998013388A1 Antibody against human parathormone related peptides |
| 04/02/1998 | WO1998013380A1 Snrnp sm proteins |
| 04/02/1998 | WO1998013067A1 Method of preventing acute rejection following solid organ transplantation |
| 04/02/1998 | WO1998013066A1 Anti-class ii mhc binding agents for use in xenotransplantation |